文献速递神经肿瘤

(原)肾素受体通过Wnt/β-catenin信号通路对胶质瘤发展至关重要

(Pro)renin receptor is crucial for glioma development via the Wnt/β-catenin signaling pathway.
PubMed 文献 · J Neurosurg · 2017-01-06

研究检测31例胶质瘤石蜡切片中(原)肾素受体(PRR)与IDH1R132H表达,并在人胶质瘤细胞系中观察PRR siRNA对增殖与凋亡的影响。发现PRR在胶质母细胞瘤中表达显著高于正常组织或低级别胶质瘤,且与Ki-67指数正相关、与患者生存时间负相关;PRR siRNA可降低Wnt2、活化β-catenin和cyclin D1表达,抑制增殖并诱导凋亡。结论认为PRR通过异常激活Wnt/β-catenin通路参与胶质瘤发展,可能既是预后标志物也是治疗靶点。

要点

  • PRR在胶质母细胞瘤中表达显著高于正常组织或低级别胶质瘤,与IDH1R132H突变无关。
  • PRR表达与Ki-67标记指数显著正相关,与胶质瘤患者生存时间显著负相关。
  • PRR siRNA降低Wnt2、活化β-catenin和cyclin D1表达,抑制胶质母细胞瘤细胞系增殖并诱导凋亡。

核心结论

  • 首次发现PRR通过异常激活Wnt/β-catenin信号通路在胶质瘤发展中起重要作用,该受体可能既是胶质瘤的预后标志物也是治疗靶点。

研究设计与样本

  • 对人胶质瘤石蜡切片31例进行免疫组化分析,检测PRR与IDH1R132H。
  • 培养人胶质瘤细胞系U251MG、U87MG和T98G,用Western blotting检测PRR及Wnt通路组分表达。
  • 用PRR siRNA处理胶质瘤细胞,以WST-1法和直接细胞计数检测增殖,以流式细胞术和caspase-3法检测凋亡。

主要发现

  • PRR在胶质母细胞瘤中的表达显著高于正常组织或低级别胶质瘤,且与IDH1R132H突变无关。
  • PRR在人胶质母细胞瘤细胞系中的表达高于人星形胶质细胞。
  • PRR表达与Ki-67标记指数呈显著正相关,与胶质瘤患者生存时间呈显著负相关。
  • PRR siRNA处理显著降低人胶质母细胞瘤细胞系中Wnt2、活化β-catenin和cyclin D1的表达。
  • PRR siRNA处理降低人胶质母细胞瘤细胞系的增殖能力并诱导凋亡。

临床怎么用

  • 作者认为PRR可能既是胶质瘤的预后标志物也是治疗靶点。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE The (pro)renin receptor (PRR) plays an essential role in the early development of the central nervous system by activating the Wnt/β-catenin signaling pathway. The authors investigated the potential role of the PRR in the pathogenesis of glioma. METHODS The authors performed immunohistochemical analysis to detect both the PRR and isocitrate dehydrogenase 1 with mutations involving arginine 132 ( IDH1R132H) in paraffin sections of 31 gliomas. Expression of the PRR and Wnt pathway components in cultured human glioma cell lines (U251MG, U87MG, and T98G) was measured using Western blotting. The effects of PRR short interfering RNA (siRNA) on glioma cell proliferation (WST-1 assay and direct cell counting) and apoptosis (flow cytometry and the caspase-3 assay) were also examined. RESULTS PRR expression was significantly higher in glioblastoma than in normal tissue or in lower grade glioma, regardless of IDH1R132H mutation. PRR expression was also higher in human glioblastoma cell lines than in human astrocytes. PRR expression showed a significant positive correlation with the Ki-67 labeling index, while it had a significant negative correlation with the survival time of glioma patients. Treatment with PRR siRNA significantly reduced expression of Wnt2, activated β-catenin, and cyclin D1 by human glioblastoma cell lines, and it reduced the proliferative capacity of these cell lines and induced apoptosis. CONCLUSIONS This is the first evidence that the PRR has an important role in development of glioma by aberrant activation of the Wnt/β-catenin signaling pathway. This receptor may be both a prognostic marker and a therapeutic target for glioma.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Kouchi M, Shibayama Y, Ogawa D, et al. (Pro)renin receptor is crucial for glioma development via the Wnt/β-catenin signaling pathway. J Neurosurg. 2017. PMID: 28059652. doi:10.3171/2016.9.JNS16431

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。